ORENASITECAN
UNII L3KV5NR5PG

Substance Identification & Data

This profile provides standardized clinical and technical data for Orenasitecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L3KV5NR5PG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2418533-89-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L3KV5NR5PG

CAS Registry Number

2418533-89-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ORENASITECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C72H86N12O20S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NIZBSXQORMTMGG-MNFWRURASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C213405

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

156903274

Unique identification number in the NCBI database of chemical substances.

INN ID

13284

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O=c1n2c(-c3c(C2)c(CC)c4c(n3)cccc4)cc5c1COC(=O)[C@]5(OC([C@@H](NC(=O)[C@H]6N(C([C@@H](NC(CCOCCOCCOCCNC(Nc7ccc(NC(N[C@H](CC(O)=O)c8cc(NS(=O)(=O)c9cc(NC(NCCC)=O)ccc9)ccc8)=O)cc7)=O)=O)CC(O)=O)=O)CCC6)C(C)C)=O)CC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Orenasitecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ORENASITECAN

Common Names & Synonyms

(4S)-4,11-DIETHYL-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1HPYRANO( 3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-4-YL N-(1-(4-((((1R)-2-CARBOXY-1-(3-(3-((PROPYLCARBAMOYL)AMINO)BENZENE-1-SULFONAMIDO)PHENYL)ETHYL)CARBAMOYL)AMINO)ANILINO)-1-OXO-5,8,11-TRIOXA-2-AZATETRADECAN-14-OYL)-L-.ALPHA.-ASPARTYL-L-PROLYL-L-VALINATE

ORENASITECAN [INN]

External Clinical & Regulatory Resources

Previous UNIIL3KU3D98YX

Next UNIIL3L0CM26R6